Thank you to yesterday’s panelists, Advanced Therapies, Jan 20-23, 2024, Dallas

Reach out to any of us on Team ViroCell in Dallas. Farzin Farzaneh, PhD Traci Kyes Nicholas Ostrout, Ph.D. Meredith Brown Elaine Rihn

Thank you to yesterday’s panelists for a lively discussion on Gene-Modified Cell Therapies: Maximizing Vector Function and Payload Delivery.

Reuben Benjamin, Haematologist, King's College London

Cécile Bauche, Chief Scientific Officer, Alaya.bio

Julie G. Allickson, PhD, Chief Technology Officer, Mayo Clinic

#ADV25 Phacilitate #lentviralvectors #retroviralvecteors #viralvectors #Advancedtherapies #biotech

Florence Buchanan